Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact Reunion Common Shareholders to Receive Consideration of US$1.12 Per Share in Cash . | June 1, 2023
Investegate announcements from BioNTech SE, BioNTech Presents Encouraging Phase 1/2 Follow-up Data for CAR-T Candidate BNT211 in Hard-To-Treat Solid Tumors at ESMO